Hawaii Healthcare
Compliance Guide

Hawaii presents a unique regulatory landscape for healthcare companies, balancing a desire for expanded access to care, particularly in its geographically dispersed communities, with a traditionally cautious approach to corporate involvement in medicine. The state has shown increasing openness to telehealth, especially post-pandemic, codifying many emergency provisions into permanent law. However, it maintains a robust Corporate Practice of Medicine (CPOM) doctrine, which significantly influences business structuring for medical, dental, and other licensed professional services. Key regulatory bodies include the Hawaii Medical Board, the Board of Nursing, the Board of Pharmacy, and the Department of Commerce and Consumer Affairs (DCCA) Professional and Vocational Licensing Division. Recent legislative actions have focused on solidifying telehealth reimbursement parity, expanding provider types eligible for telehealth, and clarifying prescribing rules for controlled substances. While the state is generally progressive in adopting telehealth technologies, companies must navigate strict professional licensing requirements, a strong CPOM stance, and specific rules around establishing patient-provider relationships and prescribing. The business climate requires careful structuring, often necessitating Professional Corporation (PC) models or Management Services Organization (MSO) arrangements that meticulously respect the CPOM. Companies expanding to Hawaii should anticipate a thorough regulatory review process and prioritize compliance with state-specific professional practice acts and administrative rules to avoid enforcement actions. The state's commitment to patient safety and professional autonomy remains paramount, shaping all aspects of healthcare delivery.

Hawaii maintains a strong Corporate Practice of Medicine (CPOM) doctrine, primarily rooted in statutory law and reinforced by regulatory interpretations. The fundamental principle is that medical decisions and the practice of medicine must be free from commercial influence and controlled by licensed professionals. This doctrine prohibits corporations, or any unlicensed individuals, from employing physicians or other licensed healthcare practitioners to provide professional services, or from otherwise exercising control over the professional judgment of licensees. The legal basis for Hawaii's CPOM is found in its professional licensing statutes, specifically Hawaii Revised Statutes (HRS) Chapter 453 (Physicians and Surgeons), Chapter 457 (Nurses), Chapter 448 (Dentists), and Chapter 461 (Pharmacists), which define the practice of each profession and limit who may engage in it. These statutes implicitly prohibit unlicensed entities from practicing medicine directly or indirectly through employment of licensed professionals. While there isn't a single, explicit 'CPOM statute,' the cumulative effect of these licensing laws and related administrative rules establishes a clear prohibition.

Ownership Structures Permitted: Generally, only licensed healthcare professionals (or entities wholly owned by licensed professionals) are permitted to own entities that directly provide professional medical services. Non-physicians or non-licensed individuals cannot own a medical practice or a significant controlling interest in one. This extends to dental practices, optometry, chiropractic, and other licensed health professions. Professional Corporations (PCs) or Professional Limited Liability Companies (PLLCs) are the typical compliant structures, where all shareholders/members must be licensed professionals of the same profession, or in some cases, closely related professions as permitted by specific board rules.

Specific Restrictions:

• Employment of Professionals: Unlicensed entities cannot employ physicians, dentists, or other licensed practitioners to provide professional services. This means a lay corporation cannot hire a doctor and bill for their services.
• Fee-Splitting: Prohibitions on fee-splitting prevent licensed professionals from sharing professional fees with unlicensed individuals or entities, or from paying for referrals. HRS § 453-8(a)(10) addresses unprofessional conduct related to fee-splitting.
• Control over Clinical Judgment: Unlicensed entities cannot dictate or interfere with the clinical judgment, treatment decisions, or professional autonomy of licensed practitioners.
• Advertising and Marketing: While MSOs can handle marketing, care must be taken to ensure advertising does not imply the MSO is providing medical services.

Impact on Telehealth, Medspas, Dental Practices, and Wellness Clinics:

• Telehealth Companies: Telehealth platforms that employ or contract with physicians and directly bill for professional services must be structured as professional entities owned by licensed professionals. Most often, a Management Services Organization (MSO) model is employed where a lay-owned MSO provides administrative and non-clinical services to a physician-owned Professional Corporation (PC) or PLLC, which alone provides the clinical services. The MSO cannot control clinical decisions or engage in fee-splitting.
• Medspas: Medspas offering medical services (e.g., injectables, laser treatments, medical-grade peels) must operate under the direct supervision and control of a licensed physician. The entity providing these medical services must be physician-owned. Non-physician ownership of the medical practice component is prohibited. MSO models are common, but the physician-owned entity must maintain full clinical and billing control.
• Dental Practices: Similar to medical practices, dental practices must be owned by licensed dentists. HRS Chapter 448 governs the practice of dentistry and implicitly prohibits corporate ownership by non-dentists.
• Wellness Clinics: If wellness clinics offer services that constitute the 'practice of medicine' (e.g., IV therapy, hormone therapy, medical weight loss with prescriptions), they fall under the CPOM restrictions and must be physician-owned and operated, or structured via a compliant MSO model.

Hawaii has established a comprehensive framework for telehealth, largely codified after the COVID-19 pandemic, aiming to expand access to care while maintaining patient safety. The primary statute governing telehealth is Hawaii Revised Statutes (HRS) Chapter 453-1.3, which defines and regulates the practice of medicine via telehealth.

Establishment of Provider-Patient Relationship: A provider-patient relationship can be established via telehealth in Hawaii. HRS § 453-1.3(b) explicitly states that 'a physician-patient relationship may be established via telehealth.' This is a critical provision, as some states require an initial in-person visit. Hawaii allows for the initial establishment of care entirely through telehealth, provided the standard of care is met.

Permitted Modalities: Hawaii is permissive regarding telehealth modalities:

• Interactive Audio-Visual (Video): This is the preferred and most common modality, allowing for real-time visual and auditory interaction. It is generally accepted for establishing new patient relationships and ongoing care.
• Audio-Only (Telephone): HRS § 453-1.3(a) defines 'telehealth' to include 'audio-only telephone calls' when used for services that are 'clinically appropriate' and meet the standard of care. This is particularly important for increasing access in rural or underserved areas, or for patients lacking reliable internet access. However, providers should exercise caution and ensure clinical appropriateness, especially for initial evaluations or complex conditions.
• Asynchronous (Store-and-Forward): This modality, involving the transmission of medical information (e.g., images, data) for review at a later time, is also permitted under the broad definition of telehealth. It is typically used for specialties like dermatology or radiology. The standard of care still applies.

Telehealth Registration Requirements: Hawaii does not currently impose separate, specific telehealth registration requirements for out-of-state providers beyond standard medical licensure. A provider must hold a full, unrestricted Hawaii license to practice medicine (or their respective profession) via telehealth to patients located in Hawaii. There is no specific 'telehealth license' or 'telehealth registration' for in-state or out-of-state practitioners, but participation in the Interstate Medical Licensure Compact (IMLC) facilitates licensure for physicians.

Informed Consent Requirements: Valid informed consent is a prerequisite for all telehealth services. HRS § 453-1.3(c) mandates that a physician providing telehealth services must 'obtain informed consent from the patient, or the patient's legal representative, for the provision of telehealth services.' This consent must include, at a minimum, information about the nature of telehealth, potential risks and benefits, confidentiality protections, and the patient's right to withdraw consent at any time. It should also cover the identity of the distant site practitioner and the patient's right to choose an in-person visit.

Geographic Restrictions: There are no specific geographic restrictions within Hawaii for telehealth delivery. Providers licensed in Hawaii can provide telehealth services to patients located anywhere within the state. For out-of-state patients, the provider must be licensed in the state where the patient is physically located during the telehealth encounter, adhering to the 'where the patient is located' rule.

Hawaii's prescribing rules for telehealth largely align with in-person prescribing standards, with specific considerations for controlled substances. The Hawaii Medical Board and the Board of Pharmacy oversee these regulations, ensuring patient safety and preventing diversion.

Controlled Substances Prescribing via Telehealth:

• Schedules II-V: Hawaii generally permits the prescribing of Schedule II, III, IV, and V controlled substances via telehealth, provided a legitimate patient-provider relationship has been established and the prescribing is for a legitimate medical purpose in the usual course of professional practice. This alignment with in-person standards was largely solidified post-COVID-19 public health emergency. The federal Ryan Haight Act requirements, which generally mandate an in-person medical evaluation before prescribing controlled substances via telemedicine, were waived during the PHE and are subject to ongoing federal rulemaking. Absent a federal waiver, Hawaii's state law would still require adherence to the federal standard for Schedule II-V controlled substances, primarily for initial prescriptions.
• Specific DEA Requirements: Providers must hold a valid DEA registration associated with their Hawaii practice address. All controlled substance prescriptions, whether issued via telehealth or in-person, must comply with federal and state electronic prescribing for controlled substances (EPCS) mandates where applicable. The DEA has proposed new rules regarding the Ryan Haight Act's applicability post-PHE, which will significantly impact initial controlled substance prescriptions via telehealth without a prior in-person visit. Providers must stay current with federal DEA guidance.

PDMP Checking Requirements: Hawaii Revised Statutes (HRS) Chapter 329-104 mandates that prescribers and dispensers must access and review the Hawaii Prescription Drug Monitoring Program (PDMP) database prior to prescribing or dispensing an opioid or benzodiazepine to a patient for the first time, and periodically thereafter (e.g., every six months for ongoing therapy). This requirement applies equally to telehealth encounters. Failure to check the PDMP is a violation and can result in disciplinary action.

Quantity or Refill Limitations: Hawaii does not impose unique quantity or refill limitations specifically for telehealth prescriptions that differ from in-person prescriptions. However, general state and federal prescribing guidelines for controlled substances apply. For example, HRS § 329-38(d) limits initial opioid prescriptions for acute pain to a seven-day supply, with exceptions for chronic pain or other conditions, which must be documented. Refills for Schedule II substances are generally prohibited, while Schedule III-V substances may have up to five refills within six months, subject to professional judgment and medical necessity.

Special Rules for Specific Drug Classes:

• GLP-1s (e.g., Semaglutide, Tirzepatide): Prescribing GLP-1 agonists for weight loss or diabetes via telehealth is permissible if clinically appropriate and the standard of care is met. Providers must conduct a thorough medical evaluation, including patient history, physical assessment (which may be conducted remotely if appropriate for the drug and patient), and laboratory tests to ensure safe and effective use. Off-label prescribing must be based on sound medical evidence and patient-specific needs.
• Hormone Therapy (e.g., Testosterone, Estrogen): Prescribing hormone replacement therapy via telehealth requires comprehensive evaluation, including lab work, and ongoing monitoring. Providers must ensure appropriate screening for contraindications and potential side effects. These are often Schedule III controlled substances (e.g., testosterone), triggering additional PDMP and federal Ryan Haight Act considerations.
• Stimulants (e.g., Adderall, Ritalin): Prescribing stimulants for ADHD or narcolepsy via telehealth is subject to the most stringent scrutiny due to their Schedule II classification. While permissible, providers must ensure a robust diagnostic process, ongoing monitoring, and adherence to all controlled substance regulations, including federal Ryan Haight Act requirements. Initial prescriptions for Schedule II stimulants via telehealth without a prior in-person evaluation remain a high-risk area, dependent on federal DEA waivers or specific state exceptions that may not fully align with federal law.

Hawaii's scope of practice laws define the services that various healthcare professionals are legally permitted to perform, influencing how healthcare businesses can utilize mid-level providers. These laws are critical for compliant staffing and service delivery.

Nurse Practitioners (NPs): Full Practice Authority: Hawaii is one of the states that grants full practice authority (FPA) to Nurse Practitioners. Hawaii Revised Statutes (HRS) Chapter 457, specifically HRS § 457-2, defines the 'practice of nursing' to include advanced practice registered nursing (APRN). An APRN, which includes NPs, can practice independently without physician supervision or a collaborative practice agreement after meeting specific licensure and experience requirements. This means Hawaii-licensed NPs can:

• Diagnose, treat, and manage acute and chronic illnesses.
• Order, perform, and interpret diagnostic tests.
• Prescribe medications, including controlled substances (Schedules II-V), within their specialty and scope, provided they hold a valid DEA registration.
• Refer patients to other healthcare professionals.
• Certify disability and sign death certificates in some circumstances.

While FPA means no formal supervision is required, NPs are still expected to practice within their individual education, training, and competence, and collaborate with other healthcare professionals when appropriate for patient care. The Hawaii Board of Nursing oversees NP practice.

Physician Assistants (PAs): Supervision Requirements: Physician Assistants in Hawaii operate under the supervision of a licensed physician. HRS Chapter 453, specifically HRS § 453-5.3, outlines the requirements for PAs. PAs can perform medical services that are within the scope of practice of their supervising physician and for which the PA is qualified by education, training, and experience. Key aspects include:

• Supervision: PAs require physician supervision, though the level of supervision can vary based on the PA's experience and the complexity of the task. Direct, on-site supervision is not always required, but the supervising physician must be readily available for consultation. The supervising physician is ultimately responsible for the PA's actions.
• Delegation: The scope of practice for a PA is determined by the supervising physician through a delegation of services agreement, which must be approved by the Hawaii Medical Board. This agreement specifies the tasks the PA is authorized to perform.
• Prescribing: PAs can prescribe medications, including controlled substances (Schedules II-V), under the direction and supervision of their collaborating physician, provided they have a valid DEA registration and meet state requirements.

Medical Assistants (MAs) in Medspas/Delegation Rules: Medical Assistants in Hawaii generally operate under the direct supervision of a physician or other licensed practitioner. Their scope of practice is limited to delegated tasks that do not require independent clinical judgment. In medspas, MAs can perform administrative tasks and certain clinical tasks that are explicitly delegated by a supervising physician, such as preparing patients for procedures, taking vital signs, and assisting with procedures. However, they cannot perform invasive procedures, administer injections (unless specifically trained and delegated for certain non-medication injections like immunizations under strict protocols), or provide medical advice. Any procedure that constitutes the 'practice of medicine' (e.g., Botox injections, dermal fillers, advanced laser treatments) must be performed by a licensed physician, APRN, or PA (under supervision). Delegation to MAs for such procedures is strictly prohibited. The Hawaii Medical Board's administrative rules provide guidance on delegation.

Navigating Hawaii's Corporate Practice of Medicine (CPOM) doctrine is paramount when structuring healthcare businesses. The primary goal is to ensure that clinical decisions and the practice of medicine remain under the control of licensed professionals, separate from commercial influence.

PC-MSO Structures: For most non-physician-owned healthcare companies (e.g., telehealth platforms, medspa chains, wellness clinics) that wish to operate in Hawaii, the Professional Corporation (PC) – Management Services Organization (MSO) model is the most common and generally compliant structure.

• Professional Corporation (PC): This entity is owned entirely by one or more Hawaii-licensed physicians (or other licensed professionals for their respective practices). The PC employs the licensed providers, holds the professional licenses, makes all clinical decisions, and bills for professional medical services. It is the entity that 'practices medicine.'
• Management Services Organization (MSO): This entity is typically a lay-owned (non-physician-owned) corporation or LLC. The MSO enters into a Management Services Agreement (MSA) with the PC. Under the MSA, the MSO provides all non-clinical, administrative, and business support services to the PC, such as office space, equipment, IT, billing, marketing, human resources for non-clinical staff, and other operational support. The MSO charges the PC a fair market value (FMV) service fee for these services.

Fee-Splitting Rules: Hawaii has strict prohibitions against fee-splitting, which is the sharing of professional fees with unlicensed individuals or entities. HRS § 453-8(a)(10) considers fee-splitting as unprofessional conduct. In an MSO arrangement, the MSO's service fee to the PC must be a fixed fee or a fee based on a legitimate cost plus a reasonable margin, and not directly tied to a percentage of the PC's professional revenue or profits. The fee must reflect the fair market value of the services provided, regardless of the volume or value of referrals or services rendered by the PC. This is crucial to avoid violating anti-kickback statutes and fee-splitting prohibitions.

Management Services Agreement (MSA) Requirements: The MSA is the cornerstone of the PC-MSO structure. It must be meticulously drafted to ensure compliance:

• Clinical Control: The MSA must explicitly state that the PC retains sole and absolute control over all clinical decisions, patient care, and professional services. The MSO cannot interfere with these aspects.
• FMV Fees: The management fee charged by the MSO to the PC must be set at fair market value for the services rendered, documented by independent valuation if necessary, and not contingent on the volume or value of services.
• Exclusive Services: The MSA should clearly delineate the administrative services provided by the MSO and the professional services provided by the PC.
• Term and Termination: Standard contract provisions regarding term, termination, and dispute resolution should be included.

Professional Corporation (PC) Requirements: To form a compliant PC in Hawaii, all shareholders must be licensed professionals of the same profession (e.g., all physicians for a medical PC). The PC must register with the DCCA. The name of the PC must comply with professional naming conventions, often including 'P.C.' or 'A Professional Corporation.'

Structuring Ownership for Compliance:

• Direct Patient Care Entities: Any entity directly providing medical, dental, or other licensed professional services must be owned by licensed professionals. This is non-negotiable.
• Ancillary Services: Entities providing purely non-clinical, administrative, or technical services (e.g., lab services, imaging centers where the professional interpretation is separate) may be lay-owned, but care must be taken to avoid any perception of practicing medicine.
• Investment: While lay investors cannot own the PC, they can invest in the MSO. The MSO then contracts with the PC. This allows for external capital while maintaining CPOM compliance.

Hawaii's regulatory landscape is dynamic, with ongoing legislative and administrative efforts to adapt to evolving healthcare delivery models, particularly telehealth. As of 2025-2026, several key areas are seeing developments:

Telehealth Expansion and Reimbursement Parity: The trend towards solidifying telehealth access and reimbursement parity continues. While many emergency measures from the COVID-19 Public Health Emergency (PHE) were codified, legislative efforts often focus on refining definitions, ensuring equitable access for all modalities (including audio-only), and mandating commercial payer parity for a broader range of services. Expect continued legislative proposals to clarify and expand HRS § 453-1.3 and HRS § 431:10A-118 (reimbursement parity). There's a push to ensure that telehealth services are reimbursed at rates comparable to in-person services, reducing financial disincentives for providers.

Controlled Substances and Telehealth (Federal Impact): The most significant recent development impacting telehealth prescribing for controlled substances is the ongoing federal rulemaking by the DEA regarding the Ryan Haight Act's applicability post-PHE. While Hawaii state law permits telehealth prescribing of controlled substances under certain conditions, federal law, absent a waiver, generally requires an in-person medical evaluation for initial prescriptions of Schedule II-V controlled substances. The DEA's proposed rules (initially in 2023, with potential revisions in 2024-2025) will dictate the future of this practice. Providers must closely monitor federal guidance, as Hawaii's state laws alone cannot supersede federal requirements for controlled substances.

Interstate Compact Participation: Hawaii is an active participant in the Interstate Medical Licensure Compact (IMLC), facilitating expedited licensure for physicians who meet the compact's requirements. This significantly streamlines the process for out-of-state physicians seeking to practice in Hawaii via telehealth. Similarly, Hawaii is part of the Nurse Licensure Compact (NLC), allowing nurses licensed in other compact states to practice in Hawaii without obtaining a separate Hawaii license. These compacts are crucial for expanding the telehealth workforce.

Enforcement Trends: The Hawaii Medical Board and other professional licensing boards continue to focus on patient safety and adherence to the standard of care in telehealth. Enforcement actions typically arise from issues related to inadequate patient evaluation, inappropriate prescribing (especially of controlled substances), lack of proper informed consent, or practicing without a valid Hawaii license. There's a growing emphasis on ensuring that telehealth providers maintain the same level of due diligence and clinical rigor as in-person care.

Medspa and Wellness Clinic Oversight: As the medspa and wellness industry grows, expect increased scrutiny from the Hawaii Medical Board regarding corporate practice of medicine violations, improper delegation of medical tasks to unlicensed personnel, and misleading advertising. There may be new administrative rules or guidance issued to clarify acceptable practices and supervision requirements for these evolving models.

Entering the Hawaii healthcare market requires meticulous planning and adherence to state-specific regulations. Here's actionable guidance for companies:

1. Understand and Respect CPOM:

• Structure First: Before any operations begin, establish a compliant PC-MSO structure if you are not a physician-owned entity. The PC must be owned by Hawaii-licensed physicians, and the MSO must provide only non-clinical services at fair market value.
• MSA is Key: Ensure your Management Services Agreement (MSA) clearly delineates roles, maintains PC clinical autonomy, and specifies FMV fees, avoiding any percentage-based revenue splits.
• No Clinical Control: Your MSO (if lay-owned) cannot influence or dictate clinical decisions, treatment protocols, or hiring/firing of clinical staff within the PC.

2. Licensure is Non-Negotiable:

• Hawaii License Required: All providers (physicians, NPs, PAs, dentists, etc.) must hold a full, unrestricted Hawaii license to treat patients located in Hawaii, regardless of telehealth modality. Leverage IMLC or NLC if applicable for expedited licensure.
• DEA Registration: Any provider prescribing controlled substances must have a Hawaii-specific DEA registration.

3. Telehealth Best Practices:

• Informed Consent: Implement a robust, documented informed consent process specifically for telehealth services, covering all state-mandated elements.
• Modality Appropriateness: While audio-only is permitted, prioritize interactive video for initial evaluations and complex cases to meet the standard of care.
• Documentation: Maintain comprehensive medical records for all telehealth encounters, equivalent to in-person visits.

4. Prescribing Compliance:

• PDMP Checks: Mandate and verify PDMP checks for all opioid and benzodiazepine prescriptions, as required by HRS Chapter 329-104.
• Controlled Substances: Stay updated on federal DEA rules regarding the Ryan Haight Act for initial controlled substance prescriptions via telehealth. Err on the side of caution and consider in-person evaluations if federal waivers are not in effect or if clinical appropriateness dictates.
• Standard of Care: Ensure all prescribing, especially for GLP-1s, hormones, or stimulants, meets the Hawaii standard of care, including appropriate diagnostic workup, lab monitoring, and follow-up.

5. Scope of Practice Adherence:

• NPs: Leverage NPs' full practice authority, but ensure they practice within their individual competence and specialty.
• PAs: Ensure all PA activities are within the scope of their supervising physician and covered by an approved delegation agreement.
• Delegation: Be extremely cautious with delegation to Medical Assistants or other unlicensed personnel, especially in medspas. Any procedure constituting the 'practice of medicine' must be performed by a licensed professional.

Common Pitfalls to Avoid:

• Assuming out-of-state licenses are sufficient for telehealth.
• Ignoring CPOM by having non-licensed individuals own or control clinical entities.
• Improper fee-splitting arrangements in MSO models.
• Inadequate patient evaluation or documentation for telehealth prescribing.
• Failure to conduct mandatory PDMP checks.

Timeline Expectations: Licensing can take several months (3-6+ months for initial medical licenses). Business entity formation (PC/MSO) is quicker (weeks), but the overall setup, including legal review of agreements, can take 6-12 months.